Kate Gasparini, PharmD, BCOP, BCPPS, discusses issues with administering oral agents in pediatric patients with cancer or patients with dysphagia.
Kate Gasparini, PharmD, BCOP, BCPPS
Advertisement
Kate Gasparini, PharmD, BCOP, BCPPS, is a pediatric oncology clinical pharmacy specialist at Memorial Sloan Kettering Cancer Center
Articles by Kate Gasparini, PharmD, BCOP, BCPPS
Kate Gasparini, PharmD, BCOP, BCPPS, discusses the oral formulation of imatinib for pediatric and adult patients with leukemias and other malignancies.
Advertisement
Latest Updated Articles
Dr Gasparini on Challenges With Oral Therapies in Pediatric Patients or Patients With DysphagiaPublished: June 18th 2025 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5